These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30016441)

  • 1. Plasma contact activation by a fucosylated chondroitin sulfate and its structure-activity relationship study.
    Lin L; Xu L; Xiao C; Zhou L; Gao N; Wu M; Zhao J
    Glycobiology; 2018 Oct; 28(10):754-764. PubMed ID: 30016441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fucosylated chondroitin sulfate oligosaccharides exert anticoagulant activity by targeting at intrinsic tenase complex with low FXII activation: Importance of sulfation pattern and molecular size.
    Li J; Li S; Yan L; Ding T; Linhardt RJ; Yu Y; Liu X; Liu D; Ye X; Chen S
    Eur J Med Chem; 2017 Oct; 139():191-200. PubMed ID: 28800457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycated albumin modulates the contact system with implications for the kallikrein-kinin and intrinsic coagulation systems.
    Hardy LJ; Bohinc D; Bane KL; Heal SL; Hethershaw E; Ali M; Palmer-Dench T; Foster R; Longstaff C; Renné T; Stavrou EX; Philippou H
    J Thromb Haemost; 2023 Apr; 21(4):814-827. PubMed ID: 36990522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfation pattern of the fucose branch is important for the anticoagulant and antithrombotic activities of fucosylated chondroitin sulfates.
    Chen S; Li G; Wu N; Guo X; Liao N; Ye X; Liu D; Xue C; Chai W
    Biochim Biophys Acta; 2013 Apr; 1830(4):3054-66. PubMed ID: 23313164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct structures of the α-fucose branches in fucosylated chondroitin sulfates do not affect their anticoagulant activity.
    Santos GR; Glauser BF; Parreiras LA; Vilanova E; Mourão PA
    Glycobiology; 2015 Oct; 25(10):1043-52. PubMed ID: 26092839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
    Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S
    J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of contact activation pathways of coagulation factor XII in plasma.
    Chatterjee K; Guo Z; Vogler EA; Siedlecki CA
    J Biomed Mater Res A; 2009 Jul; 90(1):27-34. PubMed ID: 18481791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E.
    Hojima Y; Cochrane CG; Wiggins RC; Austen KF; Stevens RL
    Blood; 1984 Jun; 63(6):1453-9. PubMed ID: 6202346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain.
    Ivanov I; Matafonov A; Sun MF; Mohammed BM; Cheng Q; Dickeson SK; Kundu S; Verhamme IM; Gruber A; McCrae K; Gailani D
    Blood; 2019 Mar; 133(10):1152-1163. PubMed ID: 30591525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease activity in single-chain prekallikrein.
    Ivanov I; Verhamme IM; Sun MF; Mohammed B; Cheng Q; Matafonov A; Dickeson SK; Joseph K; Kaplan AP; Gailani D
    Blood; 2020 Feb; 135(8):558-567. PubMed ID: 31800958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-chain factor XII: a new form of activated factor XII.
    Ivanov I; Matafonov A; Gailani D
    Curr Opin Hematol; 2017 Sep; 24(5):411-418. PubMed ID: 28604413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
    Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
    Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
    Schmaier AH
    J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A characteristic chondroitin sulfate trisaccharide unit with a sulfated fucose branch exhibits neurite outgrowth-promoting activity: Novel biological roles of fucosylated chondroitin sulfates isolated from the sea cucumber Apostichopus japonicus.
    Shida M; Mikami T; Tamura JI; Kitagawa H
    Biochem Biophys Res Commun; 2017 Jun; 487(3):678-683. PubMed ID: 28450116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII.
    Fossum S; Hoem NO; Johannesen S; Korpberget M; Nylund E; Sandem S; Briseid K
    Thromb Res; 1994 Jun; 74(5):477-85. PubMed ID: 8085248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions.
    Brunnée T; Reddigari SR; Shibayama Y; Kaplan AP; Silverberg M
    Clin Exp Allergy; 1997 Jun; 27(6):653-63. PubMed ID: 9208186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel family of insect salivary inhibitors blocks contact pathway activation by binding to polyphosphate, heparin, and dextran sulfate.
    Alvarenga PH; Xu X; Oliveira F; Chagas AC; Nascimento CR; Francischetti IM; Juliano MA; Juliano L; Scharfstein J; Valenzuela JG; Ribeiro JM; Andersen JF
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2759-70. PubMed ID: 24092749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic activity of contact factor zymogens.
    Shamanaev A; Emsley J; Gailani D
    J Thromb Haemost; 2021 Feb; 19(2):330-341. PubMed ID: 33107140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.